中国卒中杂志 ›› 2021, Vol. 16 ›› Issue (02): 101-118.DOI: 10.3969/j.issn.1673-5765.2021.02.001
王拥军,熊云云,杨佳蕾,李光硕,闫然,王文洁,瓮佳旭,上官艺
收稿日期:
2021-02-01
出版日期:
2021-02-20
发布日期:
2021-02-20
通讯作者:
王拥军 yongjunwang@ncrcnd.org.cn
Received:
2021-02-01
Online:
2021-02-20
Published:
2021-02-20
王拥军,熊云云,杨佳蕾,李光硕,闫然,王文洁,瓮佳旭,上官艺. 卒中:回眸2020[J]. 中国卒中杂志, 2021, 16(02): 101-118.
WANG Yong-Jun, XIONG Yun-Yun, YANG Jia-Lei, LI Guang-Shuo,YAN Ran, WANG Wen-Jie, WENG Jia-Xu, SHANGGUAN Yi. Highlights on Stroke Research in 2020[J]. Chinese Journal of Stroke, 2021, 16(02): 101-118.
[1] VOS T,LIM S S,ABBAFATI C,et al. Globalburden of 369 diseases and injuries in 204 countriesand territories,1990–2019:a systematic analysis forthe Global Burden of Disease Study 2019[J]. Lancet,2020,396(10258):1204-1222.[2] PHAN T G,HASEEB A,BEARE R,et al. Googlingthe lifetime risk of stroke around the world[J/OL].F11:729[2021-02-01]. https://doi.org/10.3389/f rontNeurol,2020,neur.2020.00729.[3] KRISHNAMURTHI R V,IKEDA T,FEIGIN VL. Global,regional and country-specific burdenof ischaemic stroke,intracerebral haemorrhageand subarachnoid haemorrhage:a systematicanalysis of the global burden of disease study 2017[J].Neuroepidemiology,2020,54(2):171-179.[4] WANG Y J,LI Z X,GU H Q,et al. China strokestatistics 2019:a report from the national centerfor healthcare quality management in neurologicaldiseases,China National Clinical Research Center forNeurological Diseases,the Chinese Stroke Association,National Center for Chronic and Non-communicableDisease Control and Prevention,Chinese Center forDisease Control and Prevention and Institute for GlobalNeuroscience and Stroke Collaborations[J]. StrokeVasc Neurol,2020,5(3):211-239.[5] ILIFF J J,WANG M,LIAO Y,et al. A paravascularpathway facilitates CSF flow through the brainparenchyma and the clearance of interstitial solutes,including amyloid β[J/OL]. Sci Transl Med,2012,4(147):147ra111[2021-02-01]. https://doi.org/10.1126/scitranslmed.3003748.[6] LOUVEAU A,SMIRNOV I,KEYES T J,et al.Structural and functional features of central nervoussystem lymphatic vessels[J]. Nature,2015,523(7560):337-341.[7] MESTRE H,DU T,SWEENEY A M,et al.Cerebrospinal fluid influx drives acute ischemictissue swelling[J/OL]. Science,2020,367(6483):eaax7171[2021-02-01]. https://doi.org/10.1126/science.aax7171.[8] DHAR R. Automated quantitative assessmentof cerebral edema after ischemic stroke usingCSF volumetrics[J/OL]. Neurosci Lett,2020,724:134879[2021-02-01]. https://doi.org/10.1016/j.neulet.2020.134879.[9] DHAR R,CHEN Y,HAMZEHLOO A,et al.Reduction in cerebrospinal fluid volume as an earlyquantitative biomarker of cerebral edema afterischemic stroke[J]. Stroke,2020,51(2):462-467.[10] NAGANAWA S,TAOKA T. The glymphatic system:areview of the challenges in visualizing its structure andfunction with MR imaging[J/OL]. Magn Reson MedSci,2020[2021-02-01]. https://doi.org/10.2463/mrms.rev.2020-0122.[11] LANGHORNE P,AUDEBERT H J,CADILHAC D A,et al. Stroke systems of care in high-income countries:what is optimal?[J]. Lancet,2020,396(10260):1433-1442.[12] PANDIAN J D,KALKONDE Y,SEBASTIAN I A,etal. Stroke systems of care in low-income and middleincomecountries:challenges and opportunities[J].Lancet,2020,396(10260):1443-1451.[13] MARTINS S O,MONT'ALVERNE F,REBELLO LC,et al. Thrombectomy for stroke in the public health care system of brazil[J]. N Engl J Med,2020,382(24):2316-2326.[14] YANG P F,ZHANG Y W,ZHANG L,et al.Endovascular thrombectomy with or withoutintravenous alteplase in acute stroke[J]. N Engl JMed,2020,382(21):1981-1993.[15] WANG Y T,WU X,ZHU C C,et al. Bridgingthrombolysis achieved better outcomes than directthrombectomy after large vessel occlusion:anupdated meta-analysis[J]. Stroke,2021,52(1):356-365.[16] CAMPBELL B C V,MITCHELL P J,CHURILOVL,et al. Tenecteplase versus alteplase beforethrombectomy for ischemic stroke[J]. N Engl J Med,2018,378(17):1573-1582.[17] CAMPBELL B C V,MITCHELL P J,CHURILOVL,et al. Effect of intravenous tenecteplase doseon cerebral reperfusion before thrombectomy inpatients with large vessel occlusion ischemic stroke:the EXTEND-IA TNK part 2 randomized clinicaltrial[J]. JAMA,2020,323(13):1257-1265.[18] THOMALLA G,BOUTITIE F,MA H,et al.Intravenous alteplase for stroke with unknown timeof onset guided by advanced imaging:systematicreview and meta-analysis of individual patientdata[J]. Lancet,2020,396(10262):1574-1584.[19] HILL M D,GOYAL M,MENON B K,et al.Efficacy and safety of nerinetide for the treatmentof acute ischaemic stroke(ESCAPE-NA1):amulticentre,double-blind,randomised controlledtrial[J]. Lancet,2020,395(10227):878-887.[20] TARIQ S,SAH R G,CHAN L,et al. Recanalizationfollowing endovascular treatment and imagingof perfusion,regional infarction and atrophy tounderstand stroke evolution-NA1(REPERFUSENA1)[J]. Int J Stroke,2020,15(3):343-349.[21] WANG Y J,WANG Y L,ZHAO X Q,et al.Clopidogrel with aspirin in acute minor stroke ortransient ischemic attack[J]. N Engl J Med,2013,369(1):11-19.[22] JOHNSTON S C,AMARENCO P,DENISON H,etal. Ticagrelor and aspirin or aspirin alone in acuteischemic stroke or TIA[J]. N Engl J Med,2020,383(3):207-217.[23] DING L L,LIU C,LI Z X,et al. Incorporatingartificial intelligence into stroke care and research[J/OL]. Stroke,2020,51(12):e351-e354[2021-02-01].https://doi.org/10.1161/strokeaha.120.031295.[24] RIVERA S C,LIU X,CHAN A W,et al. Guidelinesfor clinical trial protocols for interventions involvingartificial intelligence:the SPIRIT-AI extension[J].Nat Med,2020,26(9):1351-1363.[25] LIU X,CRUZ RIVERA S,MOHER D,et al.Reporting guidelines for clinical trial reports forinterventions involving artificial intelligence:theCONSORT-AI extension[J]. Nat Med,2020,26(9):1364-1374.[26] 熊云云,李子孝,丁玲玲,等. 基于人工智能干预措施的临床试验方案指南:SPIRIT-AI扩展[J]. 中国卒中杂志,2020,15(11):1228-1238.[27] 李子孝,熊云云,丁玲玲,等. 人工智能干预性临床试验报告指南:CONSORT-AI扩展[J]. 中国卒中杂志,2020,15(12):1327-1336.[28] KANSAGRA A P,GOYAL M S,HAMILTON S,etal. Collateral effect of Covid-19 on stroke evaluationin the United States[J]. N Engl J Med,2020,383(4):400-401.[29] ZHOU Y F,HONG C D,CHANG J,et al.Intravenous thrombolysis for acute ischaemic strokeduring COVID-19 pandemic in Wuhan,China:amulticentre,retrospective cohort study[J]. J NeurolNeurosurg Psychiatry,2021,92(2):226-228.[30] KERLEROUX B,FABACHER T,BRICOUT N,etal. Mechanical thrombectomy for acute ischemicstroke amid the COVID-19 outbreak:decreasedactivity,and increased care delays[J]. Stroke,2020,51(7):2012-2017.[31] AHA/ASA Stroke Council Leadership. Temporaryemergency guidance to US stroke centers during thecoronavirus disease 2019(COVID-19)pandemic:onbehalf of the American Heart Association/AmericanStroke Association Stroke Council Leadership[J].Stroke,2020,51(6):1910-1912.[32] TSIVGOULIS G,KATSANOS A H,ORNELLOR,et al. Ischemic stroke epidemiology during theCOVID-19 pandemic:navigating uncharted waterswith changing tides[J]. Stroke,2020,51(7):1924-1926.[33] LEE M H,PERL D P,NAIR G,et al. Microvascularinjury in the brains of patients with Covid-19[J]. NEngl J Med,2021,384(5):481-483.[34] IADECOLA C,ANRATHER J,KAMEL H. Effectsof COVID-19 on the nervous system[J]. Cell,2020,183(1):16-27.[35] KASHYAP V S,SCHNEIDER P A,FOTEH M,etal. Early outcomes in the ROADSTER 2 study oftranscarotid artery revascularization in patients withsignificant carotid artery disease[J]. Stroke,2020,51(9):2620-2629. |
[1] | 周宏宇, 李子孝. 数字生物标志物:打开数智医疗应用的钥匙[J]. 中国卒中杂志, 2025, 20(4): 385-390. |
[2] | 张栗源, 刘涛, 姜勇, 李子孝, 王拥军, 杨晓萌. 基于脑影像及临床特征的机器学习模型预测缺血性卒中后心房颤动[J]. 中国卒中杂志, 2025, 20(4): 392-400. |
[3] | 程相鑫, 张烁, 杜松骏, 刘子阳, 周宏宇, 贾伟丽, 李子孝, 刘涛. 基于IMU信号的人工智能上肢多关节运动状态识别系统构建——卒中后人工智能运动功能评估与检测系统建设前导研究[J]. 中国卒中杂志, 2025, 20(4): 401-409. |
[4] | 蒲善宇, 潘岳松, 王拥军. 基于无监督学习识别吲哚布芬治疗急性中重度缺血性卒中的应答患者[J]. 中国卒中杂志, 2025, 20(4): 410-417. |
[5] | 蒋兰, 傅新民, 孙梦飞, 李怡萍. 大脑中动脉闭塞性急性缺血性卒中血管内治疗后不良预后的危险因素分析及预测模型开发[J]. 中国卒中杂志, 2025, 20(4): 418-427. |
[6] | 倪佃丽, 陈晓兵, 张广慧, 彭庆荣. 急性缺血性卒中院前延迟风险预测模型的构建及评价[J]. 中国卒中杂志, 2025, 20(4): 428-434. |
[7] | 张欣悦, 常红, 赵洁, 李佩佩, 刘梦娆, 李苏爱. 急性缺血性卒中患者运动想象训练中认知负荷与生理指标的相关性研究[J]. 中国卒中杂志, 2025, 20(4): 435-446. |
[8] | 张永庆, 李娜, 高伊丽, 秦佳文, 俞海萍, 赵婷婷. 1990—2021年中国归因于高LDL-C的卒中死亡负担变化趋势及预测分析[J]. 中国卒中杂志, 2025, 20(4): 447-456. |
[9] | 王岩, 郝怀宇, 陆强, 张蕾, 沈学延, 魏桂梅. 细胞外水分比率对急性缺血性卒中患者出院结局的影响[J]. 中国卒中杂志, 2025, 20(4): 457-461. |
[10] | 胡燕琴, 赵陶丽, 李申, 郭东兴, 赵志刚. 静脉应用银杏叶制剂治疗急性缺血性卒中有效性和安全性的meta分析[J]. 中国卒中杂志, 2025, 20(4): 462-469. |
[11] | 赵乾坤, 李宪东, 徐天策, 陈会生. 基于脑-肠轴探讨针灸治疗缺血性卒中机制的基础研究进展[J]. 中国卒中杂志, 2025, 20(4): 486-492. |
[12] | 池琦, 赵颖, 韩东倩, 张锶琪, 杜沛洁, 董琬玥, 徐安定, 杨振国, 孟珩. 急性缺血性卒中发病时间评估的研究进展[J]. 中国卒中杂志, 2025, 20(4): 493-499. |
[13] | 赵开杰, 孙秀亭, 袁曼, 胡婉贞, 张晓燕. 脑侧支循环评估方法的研究进展[J]. 中国卒中杂志, 2025, 20(4): 500-510. |
[14] | 郭园丽, 高任轲, 杨彩侠, 范文凤, 郭丽娜, 董小方, 吕培华, 高欢欢, 马珂珂. 急性缺血性卒中静脉溶栓意向量表的编制及信效度检验[J]. 中国卒中杂志, 2025, 20(4): 511-518. |
[15] | 樊燕琴, 曹黎明, 任力杰. 我国社区卒中防治:医防融合视角下的卒中防治现状、挑战与策略分析[J]. 中国卒中杂志, 2025, 20(3): 261-268. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||